The week in industry: Online directory of 5300 preclinical cancer models made publicly accessible
This week: PhoreMost (Cambridge, UK) hires new Non-Executive Director, breakthrough in 3D cell technology for drug discovery and safety testing and US FDA grants Priority Review for sickle cell drug.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>